1607289

Enzyme 1991;45:188-193

©1991 S. Karger AG, Basel 0013-9432/91/0454-0188S2.75/0

Aldehyde Dehydrogenase, Aldose Reductase, and Free Radical Scavengers in Cataract M.J.C. Crabbed S.T. Hoeb “Department of Microbiology, School of Animal and Microbial Sciences, University of Reading, and b Nuffield Laboratory of Ophthalmology, University of Oxford, UK

Key Words. Bendazac • Steroids • Cyanate • Aspirin • Aldehyde dehydrogenase • Aldose reductase • Cataract Abstract. Human lens was found to contain aldehyde dehydrogenase at a level of activity similar to that of bovine lens, namely 1.76 ± 0.51 IU/g. The enzyme, which appears to be a tetramer of 229 kD, was less susceptible to inhibition by cataractogenic agents than the bovine enzyme. The lipid peroxidation product malondialdehyde was a good substrate of the human lens enzyme. The in vitro aldose reductase reaction, which we have shown is caused by glyceraldehyde-stimulated free-radical NADPH oxidation, is inhibited by the potential anti-cataract agents, bendazac acid and bendazac lysine; these compounds also inhibit ferricytochrome c reduction in the presence of DL-glyceraldchyde and scavenge superoxide rad­ icals. These results are consistent with the hypotheses that aldehyde dehydrogenase is a protective enzyme in the human lens, and that the peroxy radical scavenging effects of bendazac acid and bendazac lysine contribute to their anti-cataract activity.

The enzyme aldose reductase has been implicated in the formation of cataract, par­ ticularly in diabetics, while a protective role in cataract has been assigned to the enzyme aldehyde dehydrogenase [1]. We have shown previously that levels of ‘aldose reductase’ found in the lens are due to artifacts of monosaccharide autoxidation, and that compounds known as ‘aldose reductase in­ hibitors’ probably act in a number of ways, including peroxy radical scavenging, that do

not relate to any specific enzyme inhibition [2] , Oxygen-derived free radicals have been implicated in many disease processes affect­ ing the eye, including cataract, while free radical scavengers have been shown to de­ toxify superoxide and hydroxyl radicals in ocular tissues [1]. Bendazac and its ana­ logues have been reported to prevent ultraviolet-induced dénaturation of lens proteins [3] , to prevent X-ray-induced damage to the rabbit lens [4], to prevent cyanate binding to lens proteins and cyanate-induced phaseseparation opacities [5], to scavenge hy­ Downloaded by: University of Exeter 144.173.6.94 - 6/6/2020 4:19:02 PM

Introduction

Aldehyde Dehydrogenase, Aldose Reductase, and Free Radical Scavengers

droxyl and superoxide radicals [6], and to exhibit anti-cataract activity [7], An NAD+-dependent aldehyde dehydro­ genase that has been purified to homogene­ ity from bovine lens shows many features common to cytoplasmic liver aldehyde dehy­ drogenases, including a high Km for acetalde­ hyde, high sensitivity to disulfiram inactiva­ tion, deviation from Michaelis-Menten ki­ netics and a pi value of 5.2 [8], However, there are significant differences in native molecular weight (dimers rather than te­ tramere), amino acid composition, and the kinetic effects of metal ion-chelating re­ agents [9], While the baboon lens contains a typical cytoplasmic aldehyde dehydrogenase of unknown molecular weight [10], little or no information in available on the human lens enzyme. In this paper we attempt to study the human lens enzyme, its susceptibility to in­ hibition, its action on malondialdehyde, and the use of bendazac and its analogues as peroxy radical scavengers in an in vitro al­ dose reductase reaction.

189

was applied to the column, the homogenizing buffer described above being used as eluent. The fraction volume was 1 ml. Aldehyde Dehydrogenase Assay This was as described previously [8, 11], using sodium pyrophosphate buffer (50 mmol/1, pH 8.4), NAD+ (0.4 mmol/1) and substrate (acetaldehyde, 10 mmol/1 unless otherwise stated) at 37 °C. No alco­ hol dehydrogenase was detected under these condi­ tions when ethanol (10 or 35 mmol/1) was substituted for acetaldehyde. 1 IU of enzyme catalyses the pro­ duction of 1 pmol of NADH/min at pH 8.4 and 37 °C. Aldose Reductase Assay This was performed as described previously [12].

Ferncytochrome c Reduction Ferricytochrome c (5 pmol/1) was incubated with DL-glyceraldehyde (50 mmol/1) in potassium phos­ phate buffer (100 mmol/1, pH 6.2). The absorbance change at 550 nm was monitored using a Perkin Elmer 550 double-beam spectrophotometer as de­ scribed previously [13]. Blanks contained all reactants except glyceraldehyde. The inclusion of hypoxanthine (1 mmol/1), xanthine oxidase (10 pi) as described pre­ viously [13], together with EDTA (2 mmol/1) to lower hydroxyl radical formation through the Haber-Weiss reaction, allowed for the monitoring of peroxy (super­ oxide) radical scavenging.

Materials and Methods

Gel Chromatography A TSK HW55 column of void volume 72 ml was used at a flow rate of 15 ml/h at 4 ° C. 1 ml of human lens supernatant, protein concentration 39.3 mg/ml,

Results and Discussion The mean activity of aldehyde dehydro­ genase was 1.76 ± 0.51 IU/g of tissue. This compared closely with a corresponding value of 1.34 ± 0.11 IU/g of tissue with bovine lens. The human lens enzyme showed simi­ lar pH behaviour to the bovine lens enzyme, with the ratio of activity at pH 8.4 to that at pH 7.5 being 1.73 in both cases. Figure 1 shows the molecular weight determination of native human lens aldehyde dehydroge­ nase. The elution profile on the calibrated Downloaded by: University of Exeter 144.173.6.94 - 6/6/2020 4:19:02 PM

Human Lenses Clear human lenses from post-mortem eyes (4 male and 1 female; ages 40-65 years) were kept frozen in closed containers to prevent lyophilization. After thawing, lenses were homogenized (1 ml/lens) in icecold nitrogen-saturated phosphate buffer (20 mmol/1, pH 7.5) containing sodium azide (0.02%), EDTA (2 mmol/1) and ß-mercaptoethanol (10 mmol/1). The homogenate was centrifuged at 25,000 g for 40 min at 4°C.

190

Crabbe/Hoe

very high molecular weight material; a = a-crystallins; ß = ß-crystallins, with little resolution between heavy and light components; y = y-crystallins. Aldehyde dehydrogenase activity is expressed as the increase in absorption per minute at 340 nm due to the reduction of NAD+ to NADH. For each assay 100 pi of the eluant fraction was used in a final volume of 1 ml. Other details are in the text, o = Elution profile of human lens supernatant; ▼ = elution profile of alde­ hyde dehydrogenase activity.

column indicated a molecular weight of 229 kD, which, with a subunit molecular weight of 57 kD [8] suggests that the human lens enzyme, in common with most other aldehyde dehydrogenases, is a tetramer. However, it differs from the bovine lens en­ zyme, which is a dimer [8]. Table 1 shows the effects of cataractogenic agents as inhibi­ tors of the human lens aldehyde dehydroge­ nase activity. Generally, these agents are much poorer inhibitors of the human en­ zyme than of the bovine enzyme [11], Pro­ gesterone (10 (J.mol/1) gave only 30% inhibi­

tion of the human enzyme, compared with 75% inhibition of the bovine enzyme [IllPrednisolone, a steroid which has been shown to cause cataract in experimental ani­ mals [1], was a very weak inhibitor, while cyanate, also known to cause cataract [14] and the protective compound aspirin [15] had only limited effects at concentrations greater than 1 mmol/1. The differences in the inhibitor specificity between the human and bovine enzymes may be related to the differ­ ences in the native molecular weights, and so potential differences in numbers of subDownloaded by: University of Exeter 144.173.6.94 - 6/6/2020 4:19:02 PM

Fig. 1. Elution of human lens aldehyde dehydroge­ nase from a calibrated column of TSK HW55 of void volume 72 ml. The arrows give the elution volumes of the molecular weight markers, which were as follows: ferritin (440 kD), 93 ml; catalase (232 kD), 101 ml; yglobulin (150kD), 103 ml; bovine serum albumin (67 kD). 106 ml; ovalbumin (43 kD), 111ml; car­ bonic anhydrase (31 kD), 119 ml; lysozyme (17kD, not shown), 149 ml. The following regions were iden­ tified with the aid of polyacrylamide SDS gels; H =

Aldehyde Dehydrogenase, Aldose Reductase, and Free Radical Scavengers

191

Table 1. The effects of compounds upon the activity of the aldehyde dehydrogenase in human lens super­ natant Compound

Acetaldehyde 10 mmol/1

Control Progesterone (10 pmol/1)1 Prednisolone (100 pmol/1) Cyanate (10 mmol/1) Aspirin (4 mmol/1)

activity IU/g tissue

% activity

activity IU/g tissue

% activity

1.76

100 69 97 80 91

0.80 0.56 0.55 0.62 0.79

100 70 69 78 99

1.21

1.70 1.40 1.6

The assay with progesterone included 10% ethanol, which did not affect the activity of the enzyme.

strate/inhibitor-binding sites. Free radicalmediated lipid peroxidation, another poten­ tial cause of cataract, produces malondialdehyde. This aldehyde was a good substrate of the human lens enzyme, at an activity of 1.04 IU/g of tissue (1 mmol/1 concentration). Substrate inhibition was observed with malondialdehyde and, as was observed with the bovine enzyme [11], there was no irrevers­ ible inactivation by malondialdehyde. With malondialdehyde levels in the lens at about 2 nmol/g wet weight [16], the human lens therefore appears to contain levels of alde­ hyde dehydrogenase which would be ade­ quate to prevent cataract due to aldehydes binding to lens proteins [ 17], although it may not protect against intermediates of any free radical mechanisms which have been impli­ cated in cataract. Such mechanisms include monosaccha­ ride-induced autoxidation [13], which we have shown causes an ‘aldose reductase’ reaction by oxidizing NADPH to NADP+ in the presence of glyceraldehyde [12], Aldose

reductase had been thought to be a key en­ zyme in the aetiology of cataract in diabetics [18], although this has been severely criti­ cised [19], and aldose reductase inhibitors have recently been suggested to act by bind­ ing ‘decompartmentalized’ transition metals [20]. Both bendazac acid and bendazac ly­ sine at 5-mmol/l concentrations inhibited glyceraldehyde-stimulated NADPH oxida­ tion by 68%. This inhibition occurred in both the presence and absence of the NADPH-binding protein glutathione reduc­ tase, which enhances the free radical-me­ diated oxidation of the nucleotide. Figure 2a shows the effect of bendazac and its ana­ logues in modulating the rate of ferricytochrome c reduction, under conditions which allow DL-glyceraldehyde to autoxidise to produce hydroxyl, superoxide and carboncentred free radicals [13]. Reduced gluta­ thione and Trolox, a soluble vitamin E ana­ logue, scavenged the radicals produced by the autoxidizing glyceraldehyde, thus lower­ ing the rate of reduction. Bendazac acid and Downloaded by: University of Exeter 144.173.6.94 - 6/6/2020 4:19:02 PM

l

0.25 mmol/1

192

Crabbe/Hoe

100

Aldehyde dehydrogenase, aldose reductase, and free radical scavengers in cataract.

Human lens was found to contain aldehyde dehydrogenase at a level of activity similar to that of bovine lens, namely 1.76 +/- 0.51 IU/g. The enzyme, w...
391KB Sizes 0 Downloads 0 Views